12955_2019_1225_MOESM1_ESM.docx (14.36 kB)
MOESM1 of Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study
journal contribution
posted on 2019-10-17, 04:58 authored by Nirmish Shah, Menaka Bhor, Lin Xie, Rashid Halloway, Steve Arcona, Jincy Paulose, Huseyin YuceAdditional file 1: Table S1. Sensitivity Analysis for Discontinuation Using 30- and 60-Day Refill Gaps.